Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.…
Ingevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?
Ingevity (NYSE: NGVT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 1,400 employees.
The shares were at 53.75 USD on 20 November 2026, up 12.0% over 52 weeks. Its 52-week range is 47.35 USD to 79.29 USD: the price is 32.2% below the high and 13.5% above the low.
At a market capitalisation of 1.82B USD, it trades at 51.2 times trailing earnings and 9.0 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 33.6, a premium of 52% for NGVT.
Ingevity reports an operating margin of 25.4% and revenue down 8.4% year over year.
Its debt exceeds its cash by 1.09B USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 88.67 USD is 65.0% above the current price. The next earnings report is expected on 24 February 2027.